People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

People using weed for medical purposes are as likely -- or more -- to become addicted to cannabis as recreational tokers, a ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

As the new year gets into full swing, the South Carolina Department of Public Health is reminding Lowcountry residents that ...

To all appearances, Clark defied the typical image of someone who could be struggling with addiction. In fact ... about how ...

Sarah Potempa, founder and CEO of Beachwaver, joins CNBC's 'The Exchange' to discuss how her business will pivot if TikTok is ...